Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of 15.46% and Operating profit at 29.54% over the last 5 years
- RAW MATERIAL COST(Y) Fallen by -81.16% (YoY)
- NET SALES(Q) Highest at CNY 313.96 MM
- PRE-TAX PROFIT(Q) Highest at CNY 19.68 MM
2
With ROE of -0.27%, it has a risky valuation with a 0.85 Price to Book Value
3
Underperformed the market in the last 1 year
Stock DNA
Chemicals & Petrochemicals
CNY 2,506 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.36
0.01%
0.82
Revenue and Profits:
Net Sales:
314 Million
(Quarterly Results - Sep 2025)
Net Profit:
15 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
16.39%
0%
16.39%
6 Months
17.94%
0%
17.94%
1 Year
17.16%
0%
17.16%
2 Years
49.58%
0%
49.58%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Grandit Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
15.46%
EBIT Growth (5y)
29.54%
EBIT to Interest (avg)
-28.49
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.37
Sales to Capital Employed (avg)
86.55
Tax Ratio
96.04%
Dividend Payout Ratio
73.53%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
328.22%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.85
EV to EBIT
-21.84
EV to EBITDA
15.62
EV to Capital Employed
0.76
EV to Sales
1.31
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-3.49%
ROE (Latest)
-0.27%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
314.00
278.40
12.79%
Operating Profit (PBDIT) excl Other Income
5.60
26.80
-79.10%
Interest
0.90
1.20
-25.00%
Exceptional Items
0.40
0.20
100.00%
Consolidate Net Profit
15.20
6.40
137.50%
Operating Profit Margin (Excl OI)
17.90%
-42.90%
6.08%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is 12.79% vs 18.52% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is 137.50% vs -36.00% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,029.30
892.70
15.30%
Operating Profit (PBDIT) excl Other Income
114.90
111.00
3.51%
Interest
5.60
9.80
-42.86%
Exceptional Items
-2.90
-1.20
-141.67%
Consolidate Net Profit
11.20
14.50
-22.76%
Operating Profit Margin (Excl OI)
-37.10%
-17.80%
-1.93%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 15.30% vs 12.08% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -22.76% vs 314.29% in Dec 2023
About Grandit Co., Ltd. 
Grandit Co., Ltd.
Chemicals & Petrochemicals
No Details Available.
Company Coordinates 
No Company Details Available






